Commentary on Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model: Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C, Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY

✍ Scribed by Haojie Huang

• Book ID: 116956464
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 69 KB
• Volume: 27
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2008.12.004